Compounding warning letters to 503A facilities between 2017 and 2021
Description
CONCLUSION: The warning letter of compounding drugs issued by FDA can be used as a learning tool for compounders. Compounders can learn from the experience and lessons, improve compounding operations and reduce mistakes.
